Journal of Diabetes and Its Complications
Volume 25, Issue 2 , Pages 97-106 , March 2011

The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden

  • Lars Kärvestedt

      Affiliations

    • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Stockholms Sjukhem Foundation, Mariebergsgatan 22, S-112 19 Stockholm, Sweden. Tel.: +468 617 12 00; fax: +468 617 93 00.
    • ,
  • Eva Mårtensson

      Affiliations

    • Kronan Primary Health Care Centre, Sundbyberg, Sweden
    • ,
  • Valdemar Grill

      Affiliations

    • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    • Cancer Research and Molecular Medicine, Norwegian University of Science and Technology and St Olof Hospital, Trondheim, Norway
    • ,
  • Stig Elofsson

      Affiliations

    • Institution for Social Work, University of Stockholm, Stockholm, Sweden
    • ,
  • Gunvor von Wendt

      Affiliations

    • Department of Vitreoretinal Diseases, St. Erik's Eye Hospital, Stockholm, Sweden
    • ,
  • Anders Hamsten

      Affiliations

    • Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Kerstin Brismar

      Affiliations

    • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Received 9 November 2009 ,Revised 31 March 2010 ,Accepted 14 April 2010.

References 

  1. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes/Metabolism Research and Reviews. 2000;16(Suppl. 1):S84–S92
  2. Backlund L, Algvere P, Rosenqvist U. Fundus oculi photography. A good screening method for diabetic retinopathy. Lakartidningen. 1993;90(49):4453–4457
  3. Berger B, Stenstrom G, Chang YF, Sundkvist G. The prevalence of diabetes in a Swedish population of 280,411 inhabitants. A report from the Skaraborg Diabetes Registry. Diabetes Care. 1998;21(4):546–548
  4. Borg H, Gottsater A, Fernlund P, Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes. 2002;51:1754–1762
  5. Boulton AJ, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Medicine. 1998;15(6):508–514
  6. Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice. Neuropathic diabetic foot ulcers. New England Journal of Medicine. 2004;351(1):48–55
  7. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27(6):1458–1486
  8. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–962
  9. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia. 1998;41(11):1263–1269
  10. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817–824
  11. Falkenberg M, Finnstrom K. Associations with retinopathy in type 2 diabetes: a population-based study in a Swedish rural area. Diabetic Medicine. 1994;11(9):843–849
  12. Gorson KC, Ropper AH. Additional causes for distal sensory polyneuropathy in diabetic patients. Journal of Neurology, Neurosurgery, and Psychiatry. 2006;77(3):354–358
  13. Hove MN, Kristensen JK, Lauritzen T, Bek T. The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Aarhus County, Denmark. Acta Ophthalmologica Scandinavica. 2004;82(4):443–448
  14. International Working Group on the Diabetic Foot. (1999). International Consensus on the Diabetic Foot.
  15. Kamei N, Yamane K, Nakanishi S, Yamashita Y, Tamura T, Ohshita K, et al. Effectiveness of Semmes–Weinstein monofilament examination for diabetic peripheral neuropathy screening. Journal of Diabetes and its Complications. 2005;19(1):47–53
  16. Kärvestedt L, Mårtensson E, Grill V, Elofsson S, von Wendt G, Hamsten A, et al. Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden. Diabetes Care. 2009;32(2):317–322
  17. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes–Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Research and Clinical Practice. 1991;13(1-2):63–67
  18. Levy DM, Abraham RR, Abraham RM. Small- and large-fiber involvement in early diabetic neuropathy: a study with the medial plantar response and sensory thresholds. Diabetes Care. 1987;10(4):441–447
  19. Lundman B, Engstrom L. Diabetes and its complications in a Swedish county. Diabetes Research and Clinical Practice. 1998;39(2):157–164
  20. Maser RE, Laudadio C, DeCherney GS. The effects of age and diabetes mellitus on nerve function.. Journal of the American Geriatrics Society. 1993;41(11):1202–1204
  21. Midthjell K, Kruger O, Holmen J, Tverdal A, Claudi T, Bjorndal A, et al. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trondelag Health Surveys: 1984–1986 and 1995–1997. Diabetes Care. 1999;22(11):1813–1820
  22. NDR . Nationella Diabetesregistret (NDR), 1999 and 2010, report online. Retrieved 3 August 2006 and 17 February 2010, from http://www.ndr.nu1999;
  23. Pozzilli P, Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care. 2001;24(8):1460–1467
  24. Sima A, Sugimoto AK. Experimental diabetic neuropathy: an update. Diabetologia. 1999;42(7):773–788
  25. Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G. Latent autoimmune diabetes in adults: definition, prevalence, {beta}-cell function, and treatment. Diabetes. 2005;54(Suppl. 2):S68–S72
  26. Tesfaye S. Diabetic neuropathy. In:  Boulton AJ,  Cavanagh PR,  Rayman G editor. The Foot in Diabetes. New York: John Wiley & Sons; 2006;p. 30–40
  27. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553–1579
  28. Ward JD. The diabetic leg. Diabetologia. 1982;22(3):141–147
  29. Wiles PG, Pearce SM, Rice PJ, Mitchell JM. Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabetic Medicine. 1991;8(2):157–161
  30. Winkler AS, Ejskjaer N, Edmonds M, Watkins PJ. Dissociated sensory loss in diabetic autonomic neuropathy. Diabetic Medicine. 2000;17(6):457–462
  31. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–154

☆ The study was supported by grants from Solstickan Foundation, Heart-Lung Foundation, Familjen Erling-Persson Foundation, Swedish Diabetes Association, and Stockholms Sjukhem Foundation, and by funding from Stockholm County Council (ALF).

PII: S1056-8727(10)00043-7

doi: 10.1016/j.jdiacomp.2010.04.001

Journal of Diabetes and Its Complications
Volume 25, Issue 2 , Pages 97-106 , March 2011

Article Tools

* Image Usage & Resolution